聂文畅,刘健

• 1:北京大学人民医院心血管内科急性心肌梗死早期预警和干预北京市重点实验室

摘要(Abstract)：

冠状动脉腔内影像学因其较高的分辨率而被用以精确评估动脉壁解剖学特征，在指导经皮冠状动脉介入治疗的策略选择、效用评价等方面发挥重要作用。2021年，ILUMIEN、iSIGHT、ULTIMATE等研究为腔内影像学指导经皮冠状动脉介入治疗提供了进一步的临床证据。同时，近些年发展的近红外光谱分析技术及多模态联合的腔内影像学技术在明确病变性质、获取斑块信息等方面初步显示出应用潜力，其价值尤在急性冠状动脉综合征发生机制鉴别中得到证实。造影融合技术的应用使腔内影像与造影图像更具纵向匹配性，可在前述多重腔内影像学优势基础上进一步优化支架置入。随着上述进展在临床应用的探索，腔内影像学将被越来越高效且广泛地应用于多种复杂病变的经皮冠状动脉介入治疗中。

关键词(KeyWords)： 腔内影像学;经皮冠状动脉介入治疗;冠心病

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金重点项目（2101000483）;; 北京大学人民医院研究与发展基金热点攻关研究课题项目（2147000554）;北京大学人民医院研究与发展基金临床研究培育项目（2147000478）

作者(Author): 聂文畅,刘健

参考文献(References)：

• [1] Lawton JS,Tamis-Holland JE,Bangalore S,et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization:a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines[J]. J Am Coll Cardiol,2022,79(2):e21-e129.
• [2] Neumann FJ,Sousa-Uva M,Ahlsson A,et al. 2018 ESC/EACTS guidelines on myocardial revascularization[J]. Eur Heart J,2019,40(2):87-165.
• [3] Ali ZA,Maehara A,Généreux P,et al. Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation(ILUMIENⅢ：OPTIMIZE PCI):a randomised controlled trial[J].Lancet, 2016,388(10060):2618-2628.
• [4] Ali ZA,Karimi Galougahi K,Maehara A,et al. Outcomes of optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation:one-year results from the ILUMIENⅢ：OPTIMIZE PCI trial[J]. EuroIntervention,2021,16(13):1085-1091.
• [5] Ali Z,Landmesser U,Galougahi KK,et al. Optical coherence tomography-guided coronary stent implantation compared to angiography:a multicentre randomised trial in PCI–design and rationale of ILUMIENⅣ：OPTIMAL PCI[J].Euro Intervention,2021,16(13):1092-1099.
• [6] ChamiéD,Costa JR,Damiani LP,et al. Optical coherence tomography versus intravascular ultrasound and angiography to guide percutaneous coronary interventions[J]. Circ Cardiovasc Interv,2021,14(3):e009452.
• [7] Fujimura T,Matsumura M,Witzenbichler B,et al.S t e n t expansion indexes to predict clinical outcomes:an IVUS substudy from ADAPT-DES[J]. JACC Cardiovasc Interv,2021,14(15):1639-1650.
• [8] Gao XF,Ge Z,Kong XQ,et al. 3-Year outcomes of t h e ULTIMATE trial comparing intravascular ultrasound versus angiography-guided drug-eluting stent implantation[J]. JACC Cardiovasc Interv,2021,14(3):247-257.
• [9] Jung HW,Lim C,Bae HJ,et al. Association between in-stent neointimal characteristics and native coronary artery disease progression[J]. PLoS One,2021,16(4):e0247359.
• [10] Noguchi M,Dohi T,Okazaki S,et al. Comparison of 6-month vascular healing response after bioresorbable polymer versus durable polymer drug-eluting stent implantation in patients with acute coronary syndromes:a randomized serial optical coherence tomography study[J]. Catheter Cardiovasc Interv,2021,98(5):E677-E686.
• [11] Rai H,Alfonso F,Maeng M,et al. Optical coherence tomography tissue coverage and characterization at six months after implantation of bioresorbable scaf folds versus conventional everolimus eluting stents in the ISAR-Absorb MI trial[J]. Int J Cardiovasc Imaging,2021,37(10):2815-2826.
• [12] Song L,Xu B,Chen Y,et al. Thinner strut sirolimus-eluting BRS versus EES in patients with coronary artery disease:FUTURE-Ⅱtrial[J]. JACC Cardiovasc Interv,2021,14(13):1450-1462.
• [13] Rheude T,Rai H,Richardt G,et al. Super high-pressure balloon versus scoring balloon to prepare severely calcified coronary lesions:the ISAR-CALC randomised trial[J].EuroIntervention,2021,17(6):481-488.
• [14] Kini AS,Okamoto N,Barman N,et al. Side branch fractional flow reserve after provisional stenting of calcified bifurcation lesions:the ORBID-FFR study[J]. Catheter Cardiovasc Interv,2021,98(4):658-668.
• [15] Miura K,Tada T,Shimada T,et al. Three-dimensional optical coherence tomography versus intravascular ultrasound in percutaneous coronary intervention for the left main coronary artery[J]. Heart Vessels,2021,36(5):630-637.
• [16] Schneider VS,B?hm F,Blum K,et al. Impact of realtime angiographic co-registered optical coherence tomography on percutaneous coronary intervention:the OPTICO-integrationⅡtrial[J]. Clin Res Cardiol,2021,110(2):249-257.
• [17] Shlofmitz E,Sosa F,Goldberg A,et al. Bifurcation a n d ostial optical coherence tomography mapping(BOOM)-case description of a novel bifurcation stent technique[J].Cardiovasc Revasc Med,2018,19(8S):47-49.
• [18] Onuma Y,Okamura T,Muramatsu T,et al. New implication of three-dimensional optical coherence tomography in optimising bifurcation PCI[J]. EuroIntervention, 2015,11 Suppl V:V71-V74.
• [19] Miyazaki Y,Muramatsu T,Asano T,et al. Online threedimensional OFDI-guided versus angiography-guided PCI in bifurcation lesions:design and rationale of the randomised OPTIMUM trial[J]. EuroIntervention,2021,16(16):1333-1341.
• [20] Ge Z,Kan J,Gao XF,et al. Comparison of intravascular ultrasound-guided with angiography-guided double kissing crush stenting for patients with complex coronary bifurcation lesions:rationale and design of a prospective,randomized,and multicenter DKCRUSHⅧtrial[J]. Am Heart J,2021,234:101-110.
• [21] He L,Qin Y,Xu Y,et al. Predictors of non-stenting strategy for acute coronary syndrome caused by plaque erosion:fouryear outcomes of the EROSION study[J]. EuroIntervention,2021,17(6):497-505.
• [22] Stone GW,Maehara A,Lansky AJ,et al. A prospective naturalhistory study of coronary atherosclerosis[J]. N Engl J Med,2011,364(3):226-235.
• [23] Terada K,Kubo T,Kameyama T,et al. NIRS-IVUS for differentiating coronary plaque rupture,erosion,and calcified nodule in acute myocardial infarction[J]. JACC Cardiovasc Imaging,2021,14(7):1440-1450.
• [24] Cao M,Zhao L,Ren X,et al. Pancoronary plaque characteristics in STEMI caused by culprit plaque erosion versus rupture:3-vessel OCT study[J]. JACC Cardiovasc Imaging,2021,14(6):1235-1245.
• [25] Araki M,Yonetsu T,Kurihara O,et al. Circadian variations in pathogenesis of ST-segment elevation myocardial infarction:an optical coherence tomography study[J]. J Thromb Thrombolysis,2021,51(2):379-387.
• [26] Naito K,Nakano Y,Waseda K,et al. Impact of antiplatelet therapy on tissue prolapse at super acute phase after stenting:serial OCT study in acute coronary syndrome patients[J]. Heart Vessels,2021,36(2):200-210.
• [27] Saito S,Isshiki T,Kimura T,et al. Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in japanese patients with acute coronary syndrome[J]. Circ J,2014,78(7):1684-1692.
• [28] García-García HM,Mintz GS,Lerman A,et al. Tissue characterisation using intravascular radiofrequency data analysis:recommendations for acquisition,analysis,interpretation and reporting[J]. EuroIntervention,2009,5(2):177-189.
• [29] U eki Y,Yamaji K,Losdat S,et al. Di sc ordanc e i n the diagnostic assessment of vulnerable plaques between radiofrequency intravascular ultrasound versus optical coherence tomography among patients with acute myocardial infarction:insights from the IBIS-4 study[J]. Int J Cardiovasc Imaging,2021,37(10):2839-2847.
• [30] Oh PC,Jang AY,Ha K,et al. Ef fect of atorvastatin(10 mg)and ezetimibe(10 mg)combination compared to atorvastatin(40 mg)alone on coronary atherosclerosis[J]. Am J Cardiol,2021,154:22-28.
• [31] Fujisue K,Yamanaga K,Nagamatsu S,et al. Ef fects of statin plus ezetimibe on coronary plaques in acute coronary syndrome patients with diabetes mellitus:sub-analysis of PRECISE-IVUS trial[J]. J Atheroscler Thromb,2021,28(2):181-193.
• [32] Zanchin C,Koskinas KC,Ueki Y,et al. Ef fects of the PCSK9antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction:a serial,multivessel,intravascular ultrasound,near-infrared spectroscopy and optical coherence tomography imaging study-rationale and design of the PACMANAMI trial[J]. Am Heart J,2021,238:33-44.